| Content |
Addressing three emerging infectious diseases, namely mpox, Viral Haemorrhagic Fevers and Clostridiodes difficile and would focus on the following aspects:
•Latest epidemiology
•Strategies on surveillance
•Advances in clinical management
•Infection control measures
•Emergency preparedness
Poster
|
| Speakers |
|
Day 1
Session 1 New face of a known disease: The global outbreak of mpox 2022
|
|
Time
|
Topic
|
Speaker
|
Video
|
|
09:00-09:05
|
Welcome address
|
Dr CHEN Hong
Consultant-in-charge, Infectious Disease Control Training Centre, Hospital Authority/ Head, Infection Control Branch, Centre for Health Protection, Department of Health
|
|
|
09:05-09:50
|
WHO response for elimination of human-to-human transmission of mpox
|
Dr Rosamund LEWIS
Technical lead & Emergency Manager for mpox. Head, Smallpox Secretariat. Epidemic and Pandemic Preparedness and Prevention Department. Health Emergencies Programme. WHO
|
 |
|
09:50-10:35
|
Surveillance and public health response to mpox in Hong Kong
|
Dr K H KUNG
Principal Medical & Health Officer (Surveillance), Communicable Disease Branch, Centre for Health Protection, Department of Health
|
|
|
10:35-10:50
|
Discussion Session
|
|
|
|
10:50-11:05
|
Break
|
|
|
|
11:05-11:20
|
Mpox: Health Education and Risk Communication
|
Dr Y H LEUNG
Head, Health Promotion Branch, Centre for Health Protection, Department of Health
|
|
|
11:20-12:00
|
Clinical management of mpox: Hong Kong Experience
|
Dr Owen TSANG
Consultant (Medicine & Geriatrics), Princess Margaret Hospital/ Medical Director, Infectious Disease Centre, Hospital Authority
|
|
|
12:00-12:15
|
Discussion Session
|
|
|
|
12:15-14:00
|
Lunch Break
|
|
|
|
Session 2 Facing our worst fear bravely: Ebola and other viral hemorrhagic fevers
|
|
Time
|
Topic
|
Speaker
|
Video
|
|
14:00-14:45
|
Epidemiology and Control of Viral Hemorrhagic Fevers
|
Dr Maryam KESHTKAR-JAHROMI
Assistant Professor of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine
Medical Officer, The National Institutes of Health, the United States
|
|
|
14:45-15:30
|
Experience sharing in managing Crimean Congo Hemorrhagic Fever (CCHF)
|
Dr Maryam KESHTKAR-JAHROMI
Assistant Professor of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine
Medical Officer, The National Institutes of Health, the United States
|
|
|
15:30-15:45
|
Discussion Session
|
|
|
|
15:45-16:00
|
Break
|
|
|
|
16:00-16:30
|
Overview of Hong Kong’s preparedness plans for emerging infections
|
Dr Albert AU
Head, Emergency Response and Programme Management Branch, Centre for Health Protection, Department of Health
|
|
|
16:30-17:00
|
Proposed approach to safely transport Ebola cases in Hong Kong
|
Dr Henry WONG
Consultant (Accident and Emergency), Tuen Mun Hospital, Hospital Authority
|
|
|
17:00-17:45
|
Challenges and Opportunities of Vaccination for Ebola in Africa
|
Dr Stephen B Kennedy
Senior Researcher, UL-PIRE Africa Center, University of Liberia, Liberia
|
|
|
17:45-18:00
|
Discussion Session
|
|
|
|
Day 2
Session 3 Common yet challenging: C. difficile Infection (CDI) |
|
Time
|
Topic
|
Speaker
|
Video
|
|
09:00-09:45
|
Epidemiology and Surveillance of CDI
|
Prof Fidelma FITZPATRICK
Head of Department, Clinical Microbiology, Royal College of Surgeons in Ireland
Consultant Microbiologist, Beaumont Hospital, Dublin
|
|
|
09:45-10:00
|
Initiating surveillance in public hospitals in Hong Kong
|
Dr Leo LUI
Associate Consultant, Infectious Disease Control Training Centre, Hospital Authority/ Infection Control Branch, Centre for Health Protection, Department of Health
|
|
|
10:00-10:45
|
C. difficile: Spore to Vegetative to Spore and Everything in Between
|
Dr Paul FEUERSTADT
Assistant Clinical Professor of Medicine, Yale University School of Medicine
Assistant Clinical Professor of Medicine, Frank H. Netter School of Medicine of Quinnipiac University
|
|
|
10:45-11:00
|
Discussion Session
|
|
|
|
11:00-11:15
|
Break
|
|
|
|
11:15-12:00
|
Role of gut microbiota in the pathogenesis and therapeutics of CDI
|
Prof Qi SU
Assistant Professor (Research), Faculty of Medicine, The Chinese University of Hong Kong
|
|
|
12:00-12:45
|
One Health perspective on CDI
|
Prof Dazhi JIN
Professor, School of Medical Laboratory, Hangzhou Medical College
Director, Institute of Clinical Microbiology, Hangzhou Medical College
Chief, Key Laboratory of Biomarkers and In Vitro Diagnosis Translation of Zhejiang province
|
|
|
12:45-13:00
|
Discussion Session
|
|
|
|
13°C
20°C
18.5°C
Top